How many insider trades does FilingIQ track for VRCA?

FilingIQ tracks 340 Form 4 insider transactions for VRCA (Verrica Pharmaceuticals Inc.), covering filings from Feb 19, 2018 onwards. 0 of those were filed in the last 90 days.

Are VRCA insiders net buyers or net sellers?

Across the full Form 4 history for VRCA, 85 transactions (25%) were open-market purchases and 218 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VRCA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VRCA in?

Verrica Pharmaceuticals Inc. (VRCA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $79.37M.

VRCA insider trading

NasdaqCM Healthcare

Verrica Pharmaceuticals Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

340

Last 90 days

Buys / sells

25% / 64%

Market cap

$79.37M

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Company website: www.verrica.com

VRCA insider activity at a glance

FilingIQ has scored 340 insider transactions for VRCA since Feb 19, 2018. The most recent filing in our index is dated Dec 23, 2025.

Across the full history, 85 open-market purchases and 218 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VRCA insider trades is 55.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VRCA trades on FilingIQ Raw filings on SEC EDGAR

Latest VRCA Form 4 filings

White Ted President and CEO

S Nov 14, 2023

White Ted President and CEO

S Jul 24, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VRCA?: FilingIQ tracks 340 Form 4 insider transactions for VRCA (Verrica Pharmaceuticals Inc.), covering filings from Feb 19, 2018 onwards. 0 of those were filed in the last 90 days.
Are VRCA insiders net buyers or net sellers?: Across the full Form 4 history for VRCA, 85 transactions (25%) were open-market purchases and 218 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VRCA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VRCA in?: Verrica Pharmaceuticals Inc. (VRCA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $79.37M.

Methodology & sources

Every VRCA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.